Signaling Pathways - IRAK - MARK1 - Tryptophan hydroxylases (TPH) - Androgen Receptors
清除全部
-
A8452 ODM-201中文名: 达洛鲁胺Target: Androgen ReceptorsSummary: 新一代雄激素受体抑制剂 -
B1326 DL-Adrenaline中文名: DL-肾上腺素Target: Androgen ReceptorsSummary: 肾上腺素能受体激动剂 -
B3247 TelotristatTarget: Tryptophan hydroxylases (TPH)Summary: TPH inhibitor -
A8623 TOK-001中文名: 加来特龙,伽来特隆Target: Androgen Receptors|Cytochrome P450 (CYP450)Summary: CYP17抑制剂和雄激素受体（AR）拮抗剂 -
A2150 AndarineTarget: Androgen ReceptorsSummary: 雄激素受体拮抗剂 -
A5065 Bicalutamide1 Citation中文名: 比卡鲁胺Target: Androgen ReceptorsSummary: 雄激素受体（Androgen receptor）拮抗剂 -
A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe抑制剂 -
A3565 LX-1031Target: Tryptophan hydroxylases (TPH)Summary: TPH抑制剂 -
A3505 IRAK-1-4 Inhibitor I3 CitationTarget: IRAKSummary: IRAK-1/4抑制剂 -
A3504 IRAK inhibitor 6Target: IRAKSummary: IRAK-4抑制剂